RABEPRAZOLE KRKA 10 mg, gastro-resistant tablet 14 tablets
Active ingredients: RABÉPRAZOLE BASE, Rabeprazole sodium
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RABEPRAZOLE KRKA 10 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) formée(s) à froid polyamide aluminium PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64710550CIP74949557CIP133400949495573Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RABÉPRAZOLE BASEcomprimé | 9,42 mg · un comprimé | FT |
| RABÉPRAZOLE SODIQUEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.